The role of Gal-3 as a central mediator of cardiovascular fibrosis and the inflammatory processes present in different pathological situations has been amply demonstrated (Calvier et al., 2013, 2015; Martinez-Martinez et al., 2014, 2015a,b). This evidence concerns the gene LGALS3 and fibrosis.